Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
01 May 2024 //
BUSINESSWIRE
FDA Authorizes Phase 2 of DB107 In Promising Turn-Around of Targeted Treatment
25 Jul 2023 //
BUSINESSWIRE
01 May 2024 //
BUSINESSWIRE
25 Jul 2023 //
BUSINESSWIRE